ICD-10 Coding for Hyperaldosteronism(E26.0, E26.0N, E26.0P)
Comprehensive guide to ICD-10 coding for hyperaldosteronism, including primary and secondary forms, documentation requirements, and coding pitfalls.
Complete code families applicable to Hyperaldosteronism
Compare key differences between these codes to ensure accurate selection
| Code | Description | When to Use | Key Documentation |
|---|---|---|---|
| E26.0 | Primary hyperaldosteronism | Use when autonomous aldosterone secretion is confirmed. |
|
| E26.1 | Secondary hyperaldosteronism | Use when aldosterone excess is due to another condition. |
|
Clinical Decision Support
Always review the patient's clinical documentation thoroughly. When in doubt, choose the more specific code and ensure documentation supports it.
Key Information
Essential facts and insights aboutHyperaldosteronism
Alternative codes to consider when ruling out similar conditions
Documentation & Coding Risks
Avoid these common issues when documenting Hyperaldosteronism.
Using unspecified codes without complete workup
Impact
Clinical: Leads to inadequate treatment planning., Regulatory: Non-compliance with coding standards., Financial: Potential revenue loss due to claim denials.
Mitigation
Complete diagnostic workup before coding., Query providers for specificity.
Mixing primary and secondary codes without proper documentation
Impact
Reimbursement: Incorrect coding can lead to claim denials., Compliance: Non-compliance with coding guidelines., Data Quality: Poor data quality affecting clinical decisions.
Mitigation
Ensure confirmatory tests and linkage to underlying conditions are documented.
E26.0 without confirmatory testing
Impact
Coding E26.0 without documented confirmatory tests can trigger audits.
Mitigation
Ensure all confirmatory tests are documented in the patient's record.